Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT04478695 · TERMINATED
Trial details
- NCT number
- NCT04478695
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-29
- Primary completion
- 2020-10-23
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.